← Back to Search

Dietary Supplement

Nutritional Supplements for Post-COVID Brain Fog

N/A

Recruiting

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Confirmed COVID infection, at least 3 months previously, with ongoing cognitive complaints

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-months

Awards & highlights

Study Summary

This trial will study brain "fog" in people with long-COVID, testing two different supplemental oils to see if it can help. Participants will get brain tests and be asked questions.

Who is the study for?

This trial is for individuals aged 22-50 who had a confirmed COVID infection at least 3 months ago and are experiencing ongoing 'brain fog'. They must have stable medical conditions and, if taking medications, be on stable doses. People cannot join if they can't speak English, didn't confirm their COVID with a test, or had cognitive issues before COVID.Check my eligibility

What is being tested?

The study is testing the effects of two dietary oils - medium chain triglyceride oil and safflower oil - on post-COVID 'brain fog'. Participants will consume one type of oil daily and undergo brain function tests to see if there's any improvement in their symptoms.See study design

What are the potential side effects?

Potential side effects from consuming the oils may include digestive discomfort such as nausea or diarrhea. Since these are common edible oils, severe side effects are not typically expected but individual reactions can vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had COVID-19 over 3 months ago and still have thinking or memory problems.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cognigram(R)

Secondary outcome measures

Montreal Cognitive Assessment

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: InterventionExperimental Treatment1 Intervention

Medium chain triglyceride oil 15ml tid x 5 months

Group II: PlaceboPlacebo Group1 Intervention

Safflower oil 15mls tid x 5 months

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

medium chain triglyceride oil

2017

N/A

~30

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

889 Previous Clinical Trials

385,077 Total Patients Enrolled

12 Trials studying COVID-19

4,561 Patients Enrolled for COVID-19

Media Library

Medium Chain Triglyceride Oil (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05705648 — N/A

COVID-19 Research Study Groups: Placebo, Intervention

COVID-19 Clinical Trial 2023: Medium Chain Triglyceride Oil Highlights & Side Effects. Trial Name: NCT05705648 — N/A

Medium Chain Triglyceride Oil (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05705648 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to become a subject in this experiment?

"Prospective enrollees for this clinical trial must be aged between 22 and 50, have long covid symptoms, and out of the 100 participants being accepted."

Answered by AI

Are participants under 25 permitted to join this experiment?

"According to the criteria for this investigation, those aged between 22 and 50 are eligible for participation. In contrast, 3 trials exist specifically targeted at individuals below 18 years old while 36 studies accommodate elderly citizens over 65."

Answered by AI

Are there any available slots for patients to participate in this research endeavor?

"According to clinicaltrials.gov, this research is not in the recruitment phase at present. Initially uploaded on March 6th 2023 and last updated January 27th 2023, it does not require any new participants for now; however, there are 48 other trials actively recruiting patients currently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Nutritional Management of Post COVID-19 Cognitive Symptoms

Angela Juby 2023. "Nutritional Management of Post COVID-19 Cognitive Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05705648.

All > Survivor Corps